The Ickes and Enright Group (on Behalf of Greater New York Hospital Association)
Hospital trade association.
Based in DC
🤖
AI Overview
With $2.3M in lobbying spend across 29 quarterly filings, The Ickes and Enright Group (on Behalf of Greater New York Hospital Association) is a significant lobbying presence.
$2.3M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
6
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $320K |
| 2019 | $240K |
| 2020 | $320K |
| 2021 | $240K |
| 2022 | $320K |
| 2023 | $320K |
| 2024 | $240K |
| 2025 | $320K |
Lobbying Firms
TIBER CREEK GROUP
What They Lobby For
- Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education. Disproportionate Share Hospital Funding.
- Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education.
- Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education. S. 2843/H.R. 5818, The Opioid Workforce Act and H.R. 2267/S. 1301, Resident Physician Shortage Reduction Act of 2017.
- Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education. S. 2843/H.R. 5818, The Opioid Workforce Act and H.R. 2267/S. 1301, Resident Physician Shortage Reduction Act of 2017. Liver Allocation Fairness Act, H.R. 6517
- Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education. H.R. 2267/S. 1301, Resident Physician Shortage Reduction Act of 2017. Liver Allocation Fairness Act, H.R. 6517
- Issues related to organ transplantation
- Issues related to implementation of PPACA (Pub. L. No. 111 -148) that impact hospital funding, general Medicare and Medicaid issues, and funding for graduate medical education
- Issues related to implementation of PPACA (Pub. L. No. 111 -148) that impact hospital funding, general Medicare and Medicaid issues, and funding for graduate medical education including the Opioid Workforce Act, H.R. 2439, and the Resident Physician Shortage Reduction Act of 2019, H.R. 1763/S. 348
- Issues related to organ transplantation. Federal COVID response, including Coronavirus Preparedness and Response Supplemental Appropriations Act (Public Law No. 116-123), Families First Coronavirus Response Act (Public Law No. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (Public Law 116-136)
- General Medicare and Medicaid issues, and funding for graduate medical education including the Opioid Workforce Act, H.R. 2439, and the Resident Physician Shortage Reduction Act of 2019, H.R. 1763/S. 348. Federal COVID response, including Coronavirus Preparedness and Response Supplemental Appropriations Act (Public Law No. 116-123), Families First Coronavirus Response Act (Public Law No. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (Public Law 116-136)
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.